We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIBK icon
2926
First Interstate BancSystem
FIBK
$3.73B
$3.04M ﹤0.01%
75,837
-31,995
-30% -$1.24M
PDCO
2927
DELISTED
Patterson Companies, Inc.
PDCO
$3.04M ﹤0.01%
84,008
-434,130
-84% -$15.8M
CIR
2928
DELISTED
CIRCOR International, Inc
CIR
$3.04M ﹤0.01%
62,348
-25,909
-29% -$1.27M
AN icon
2929
CALL
AutoNation
AN
$6.92B
$3.03M ﹤0.01%
59,100
-58,200
-50% -$2.95M
UA icon
2930
PUT
Under Armour Class C
UA
$2.26B
$3.03M ﹤0.01%
227,500
-189,000
-45% -$2.47M
FMI
2931
CALL
DELISTED
Foundation Medicine, Inc.
FMI
$3.03M ﹤0.01%
44,400
+29,300
+194% +$1.52M
CIT
2932
CALL
DELISTED
CIT Group Inc.
CIT
$3.03M ﹤0.01%
61,500
-8,700
-12% -$422K
ASTE icon
2933
Astec Industries
ASTE
$997M
$3.02M ﹤0.01%
51,695
+22,276
+76% +$1.19M
SQQQ icon
2934
PUT
ProShares UltraPro Short QQQ
SQQQ
$1.68B
$3.02M ﹤0.01%
56
+32
+133% +$1.85M
DDD icon
2935
PUT
3D Systems Corp
DDD
$616M
$3.02M ﹤0.01%
349,800
-5,500
-2% -$56.6K
PAYC icon
2936
CALL
Paycom
PAYC
$9.83B
$3.02M ﹤0.01%
37,600
+8,300
+28% +$664K
SAM icon
2937
CALL
Boston Beer
SAM
$1.91B
$3.02M ﹤0.01%
15,800
-7,400
-32% -$1.32M
EWG icon
2938
PUT
iShares MSCI Germany ETF
EWG
$1.68B
$3.02M ﹤0.01%
91,400
+32,300
+55% +$1.06M
HT
2939
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$3.02M ﹤0.01%
173,360
-64,394
-27% -$1.15M
SIOX
2940
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$3.02M ﹤0.01%
71,550
-89,176
-55% -$4M
GSIE icon
2941
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
$3.02M ﹤0.01%
+100,501
New +$2.96M
MOMO
2942
CALL
Hello Group
MOMO
$850M
$3.01M ﹤0.01%
122,900
-11,800
-9% -$340K
NCI
2943
DELISTED
Navigant Consulting, Inc.
NCI
$3M ﹤0.01%
154,678
+444
+0.3% +$8.05K
WBC
2944
CALL
DELISTED
WABCO HOLDINGS INC.
WBC
$3M ﹤0.01%
20,900
+3,800
+22% +$558K
FARO
2945
DELISTED
Faro Technologies
FARO
$2.99M ﹤0.01%
63,700
-3,332
-5% -$156K
MPLX icon
2946
PUT
MPLX
MPLX
$60.3B
$2.99M ﹤0.01%
84,400
+40,700
+93% +$1.43M
ECL icon
2947
CALL
Ecolab
ECL
$77.4B
$2.99M ﹤0.01%
22,300
-10,800
-33% -$1.44M
SONY icon
2948
CALL
Sony
SONY
$142B
$2.99M ﹤0.01%
332,500
+7,000
+2% +$60.1K
FFIV icon
2949
F5
FFIV
$22.8B
$2.99M ﹤0.01%
22,766
-12,641
-36% -$1.57M
NWN icon
2950
Northwest Natural Holdings
NWN
$2.14B
$2.98M ﹤0.01%
50,052
+44,137
+746% +$2.89M

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.